2019
DOI: 10.1016/j.biopha.2018.12.102
|View full text |Cite
|
Sign up to set email alerts
|

MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

4
28
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(32 citation statements)
references
References 25 publications
4
28
0
Order By: Relevance
“…[ 30 ] In addition, overexpression of miR-31–5p significantly inhibited renal cell carcinoma progression in vitro through targeting CDK1. [ 31 ] Similar association was identified in the present study that CDK1 was upregulated in HCC and higher expression of CDK1 correlated with worse survival of HCC patients. Taken together, these data indicated that CDK1 may act as a potential biomarker for predicting the survival in HCC.…”
Section: Discussionsupporting
confidence: 89%
“…[ 30 ] In addition, overexpression of miR-31–5p significantly inhibited renal cell carcinoma progression in vitro through targeting CDK1. [ 31 ] Similar association was identified in the present study that CDK1 was upregulated in HCC and higher expression of CDK1 correlated with worse survival of HCC patients. Taken together, these data indicated that CDK1 may act as a potential biomarker for predicting the survival in HCC.…”
Section: Discussionsupporting
confidence: 89%
“…Nevertheless, the role of miR-31-5p in RCC pathogenesis is not without inconsistencies. A previous study suggested that miR-31-5p may act as a tumor suppressor in RCC by inhibiting proliferation, migration, and invasion via targeting cyclin-dependent kinase 1 (Li et al, 2019). Moreover, the expression of miR-31-5p has been reported to be significantly lower in RCC tissue and cell lines (Li et al, 2019).…”
Section: Circulating Mirnas As Predictive Biomarkers For Therapy Respmentioning
confidence: 99%
“…A previous study suggested that miR-31-5p may act as a tumor suppressor in RCC by inhibiting proliferation, migration, and invasion via targeting cyclin-dependent kinase 1 (Li et al, 2019). Moreover, the expression of miR-31-5p has been reported to be significantly lower in RCC tissue and cell lines (Li et al, 2019). Gamez-Pozo et al (2012) developed several predictive models of miRNA expression in the peripheral blood for resistance to sunitinib therapy in a prospective observational multicenter study including 38 metastatic RCC patients who received firstline treatment with sunitinib.…”
Section: Circulating Mirnas As Predictive Biomarkers For Therapy Respmentioning
confidence: 99%
“…24 MiR-31-5p is considered to be a tumor suppressor in renal cell carcinoma because its overexpression can inhibit cell proliferation, invasion and cell cycle. 25 In bladder cancer, knockdown of circRNA-BPTF could increase miR-31-5p expression to restrain the proliferation and metastasis of bladder cancer. 26 Therefore, the anti-proliferation and antimetastasis effects of miR-31-5p might better elucidate the molecular mechanism of its interacting targets.…”
Section: Discussionmentioning
confidence: 99%